Publication Cover
Acta Clinica Belgica
International Journal of Clinical and Laboratory Medicine
Volume 43, 1988 - Issue 4
1
Views
1
CrossRef citations to date
0
Altmetric
Original Articles

Bone Marrow Transplantation for Poor Prognosis All in Children. Relapse Rate, Infections and Immunological Recovery

, , , , , & show all
Pages 254-260 | Published online: 17 May 2016
 

Summary

Between 1980 and 1985, 11 children (8 boys, 3 girls aged between 18 months and 16 years) with poor prognosis ALL (Acute Lymphoblastic Leukaemia) were treated with ablative therapy and allogeneic bone marrow transplantation. Six patients (55 %) are alive at the time of evaluation , one died in aplasia, two died of interstitial pneumonia and two died of bone marrow relapse.

The median time to recover a neutrophil count of 0.5 x 109/1 was 19 days. The total number of lymphocytes reached normal values after 6 months. The percentage of OKT3 cells (mature T lymphocytes) was slightly depressed during the first 3 months. For at least 9 months, the number of OKT4 (helper lymphocytes) was low with a normal number of OKT8 (suppressor lymphocytes) resulting in an OKT4/OKT8 inverted ratio.

As far as B lymphocytes function was concerned, there was a moderate decrease of the immunoglobulin levels. Normal values were obtained after 3 months for IgG, 6 months for IgA and IgM.

All the immunological parameters tested returned to normal within one year after the bone marrow transplantation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.